Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization Company to Exhibit at American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2025 GlobeNewswire October 21, 2025 DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today […]

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure GlobeNewswire October 21, 2025 Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New

NIH Grant Awarded to Further Research of Novel Chemical Pathway to Reverse MCI Levels of acetylcholine drop as we age–previously, nothing has been shown to reverse that GlobeNewswire October 21, 2025 SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) — The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ

RTI Connext Recognized as the Gold Standard for Accelerating Defense System Deployment This award validates the key role Connext plays in delivering secure, interoperable, and rapidly fielded systems for the U.S. and its allies GlobeNewswire October 21, 2025 SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Real-Time Innovations (RTI), the software framework company for physical

Discover the Extraordinary: Preferred Hotels & Resorts Presents Annual Live Like a Legend Experiences for 2025 The World's Largest Independent Hotel Brand Unveils Six Dream-worthy and Inspiring Luxury Travel Experiences, Offering Unforgettable, Rare Access to the Truly Exceptional GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Setting a new benchmark for

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved GlobeNewswire October 21, 2025 Minerva secures $80 million up front and up

Restaurants could create 25,000 additional youth jobs with boost from permanent GST exemption GlobeNewswire October 21, 2025 Toronto, Oct. 21, 2025 (GLOBE NEWSWIRE) — The federal government could add more than 25,000 youth jobs in the foodservice industry by eliminating the GST from restaurant meals, according to analysis by Restaurants Canada. The foodservice industry already

Retail Investor Advocate Eric Jackson to join ProCap Financial Board of Directors GlobeNewswire October 21, 2025 â— ProCap BTC takes a bold step toward aligning corporate governance with the interests of everyday investors New York, NY, Oct. 21, 2025 (GLOBE NEWSWIRE) — Retail investors have increasingly become a driving force in the financial markets. While

Simcha Therapeutics Presents Preclinical Data Demonstrating Potential for Decoy-Resistant IL-18 to Enhance Efficacy of Bi-specific T-cell Engagers Findings presented at European Society for Medical Oncology include models in solid tumors and hematologic malignancies GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., and NEW HAVEN, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — Simcha Therapeutics (“Simcha”), a

New TransUnion Research Reveals Marketers' Confidence in Measurement Has Stalled AI Adoption and long-term ROI strategies on the rise as most marketers face internal skepticism GlobeNewswire October 21, 2025 CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Marketers' confidence in measurement has plateaued at a time when it should be rising, according to new research from